Vitality Biopharma, Inc. (OTCQB: VBIO, “Vitality”). is focused on the development of cannabinoids for the treatment of serious neurological and inflammatory disorders. Vitality’s development pipeline is focused on a new class of cannabinoid prodrug pharmaceuticals called cannabosides. Cannabosides … Read More
The post SeeThruEquity Issues Update on Vitality Biopharma, Inc. (VBIO) appeared first on Dagga Magazine.